Estimating the serial intervals of SARS-CoV-2 Omicron BA.4, BA.5, and BA.2.12.1 variants in Hong Kong

被引：5
|
作者：
Guo, Zihao [1 ]
Zhao, Shi [1 ,2 ]
Yam, Carrie Ho Kwan [1 ,2 ]
Li, Conglu [1 ]
Jiang, Xiaoting [1 ]
Chow, Tsz Yu [1 ,2 ]
Chong, Ka Chun [1 ,2 ]
Yeoh, Eng Kiong [1 ,2 ]
机构：
[1] Chinese Univ Hong Kong, Fac Med, JC Sch Publ Hlth & Primary Care, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Fac Med, Ctr Hlth Syst & Policy Res, Hong Kong, Peoples R China
来源：
INFLUENZA AND OTHER RESPIRATORY VIRUSES | 2023年 / 17卷 / 02期
基金：
中国国家自然科学基金;
关键词：
COVID-19; disease transmission; Hong Kong; SARS-CoV-2 omicron variant; serial infection interval;
D O I：
10.1111/irv.13105
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Empirical evidence on the epidemiological characteristics of the emerged SARS-CoV-2 variants could shed light on the transmission potential of the virus and strategic outbreak control planning. In this study, by using contact tracing data collected during an Omicron-predominant epidemic phase in Hong Kong, we estimated the mean serial interval of SARS-CoV-2 Omicron BA.4, BA.5, and BA.2.12.1 variants at 2.8 days (95% credible interval [CrI]: 1.5, 6.7), 2.7 days (95% CrI: 2.1, 3.6), and 4.4 days (95% CrI: 2.6, 7.5), respectively, with adjustment for right truncation and sampling bias. The short serial interval for the current circulating variant indicated that outbreak mitigations through contact tracing and case isolation would be quite challenging.
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants
    Altarawneh, Heba N.
    Chemaitelly, Hiam
    Ayoub, Houssein H.
    Hasan, Mohammad R.
    Coyle, Peter
    Yassine, Hadi M.
    Al-Khatib, Hebah A.
    Smatti, Maria K.
    Al-Kanaani, Zaina
    Al-Kuwari, Einas
    Jeremijenko, Andrew
    Kaleeckal, Anvar H.
    Latif, Ali N.
    Shaik, Riyazuddin M.
    Abdul-Rahim, Hanan F.
    Nasrallah, Gheyath K.
    Al-Kuwari, Mohamed G.
    Butt, Adeel A.
    Al-Romaihi, Hamad E.
    Al-Thani, Mohamed H.
    Al-Khal, Abdullatif
    Bertollini, Roberto
    Tang, Patrick
    Abu-Raddad, Laith J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022,
  • [32] Association of SARS-CoV-2 BA.4/BA.5 Omicron lineages with immune escape and clinical outcome
    Joseph A. Lewnard
    Vennis Hong
    Jeniffer S. Kim
    Sally F. Shaw
    Bruno Lewin
    Harpreet Takhar
    Sara Y. Tartof
    Nature Communications, 14
  • [33] Association of SARS-CoV-2 BA.4/BA.5 Omicron lineages with immune escape and clinical outcome
    Lewnard, Joseph A.
    Hong, Vennis
    Kim, Jeniffer S.
    Shaw, Sally F.
    Lewin, Bruno
    Takhar, Harpreet
    Tartof, Sara Y.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [34] SARS-CoV-2 Omicron variants BA.4 and BA.5 dominated the fifth COVID-19 epidemiological wave in Mexico
    Taboada, Blanca Itzelt
    Zarate, Selene
    Garcia-Lopez, Rodrigo
    Munoz-Medina, Jose Esteban
    Gomez-Gil, Bruno
    Herrera-Estrella, Alfredo
    Sanchez-Flores, Alejandro
    Salas-Lais, Angel Gustavo
    Roche, Benjamin
    Martinez-Morales, Gabriela
    Zarate, Hermilo Dominguez
    Molina, Celida Duque
    Hernandez, Ricardo Aviles
    Lopez, Susana
    Arias, Carlos F.
    MICROBIAL GENOMICS, 2023, 9 (12):
  • [35] Update on the omicron sub-variants BA.4 and BA.5
    Tallei, Trina Ekawati
    Alhumaid, Saad
    AlMusa, Zainab
    Fatimawali
    Kusumawaty, Diah
    Alynbiawi, Ahlam
    Alshukairi, Abeer N.
    Rabaan, Ali A.
    REVIEWS IN MEDICAL VIROLOGY, 2023, 33 (01)
  • [36] Real-world effectiveness of nirmatrelvir-ritonavir against BA.4 and BA.5 omicron SARS-CoV-2 variants
    Wong, Carlos K. H.
    Lau, Kristy T. K.
    Leung, Gabriel M.
    LANCET INFECTIOUS DISEASES, 2023, 23 (06): : 639 - 640
  • [37] Omicron BA.2突破性感染可增强BA.2.12.1和BA.4/BA.5的交叉中和作用
    赵林
    广东药科大学学报, 2023, 39 (01) : 152 - 152
  • [38] A booster of Delta-Omicron RBD-dimer protein subunit vaccine augments sera neutralization of Omicron sub-variants BA.1/BA.2/BA.2.12.1/BA.4/BA.5
    Duan, Minrun
    Duan, Huixin
    An, Yaling
    Zheng, Tianyi
    Wan, Shengfeng
    Wang, Hui
    Zhao, Xin
    Dai, Lianpan
    Xu, Kun
    Gao, George F.
    EMERGING MICROBES & INFECTIONS, 2023, 12 (01)
  • [39] Fifth bivalent omicron BA.4/BA.5 vaccination neutralization of SARS-CoV-2 in heart transplant recipients
    Peled, Yael
    Afek, Arnon
    Patel, Jignesh K.
    Raanani, Ehud
    Segev, Amit
    Ram, Eilon
    Fardman, Alexander
    Beigel, Roy
    Atari, Nofar
    Kliker, Limor
    Abd Elkader, Bayan
    Mandelboim, Michal
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (08): : 1054 - 1058
  • [40] Exposure to BA.4/5 S protein drives neutralization of Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 in vaccineexperienced humans and mice
    Muik, Alexander
    Lui, Bonny Gaby
    Bacher, Maren
    Wallisch, Ann-Kathrin
    Toker, Aras
    Couto, Carla Iris Cadima
    Gueler, Alptekin
    Mampilli, Veena
    Schmitt, Geneva J.
    Mottl, Jonathan
    Ziegenhals, Thomas
    Fesser, Stephanie
    Reinholz, Jonas
    Wernig, Florian
    Schraut, Karla-Gerlinde
    Hefesha, Hossam
    Cai, Hui
    Yang, Qi
    Walzer, Kerstin C.
    Grosser, Jessica
    Strauss, Stefan
    Finlayson, Andrew
    Kruger, Kimberly
    Ozhelvaci, Orkun
    Grikscheit, Katharina
    Kohmer, Niko
    Ciesek, Sandra
    Swanson, Kena A.
    Vogel, Annette B.
    Tuereci, Oezlem
    Sahin, Ugur
    SCIENCE IMMUNOLOGY, 2022, 7 (78)
12345